Targets of perturbagens

Perturbagen ID Perturbagen Reference Target Number Response ID
CID54521 Ico-007 DrugBank 1  NA
CID54522 Hbig; Hepagam b; Hepatitis b immune globulin; Hepatitis b immune globulin (human); Human hepatitis b immunoglobulin; Human hepatitis b virus immune globulin; Human hepatitis-b immunoglobulin; Hyperhep b s/d; Nabi-hb DrugBank 1  NA
CID54523 S-8184 DrugBank 2  NA
CID54524 Mcc DrugBank 1  NA
CID54525 Ca4p DrugBank 1  NA
CID54526 (−)-(2r)-2-(2-fluorobiphenyl-4-yl)propanoic acid; (2r)-2-(2-fluorobiphenyl-4-yl)propanoic acid; (r)-2-fluoro-α-methyl(1,1'-biphenyl)-4-acetic acid; (r)-flurbiprofen; Tarenflurbil DrugBank 1  NA
CID54527 Spp 301 DrugBank 1  NA
CID54528 Caprelsa; N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-4-quinazolinamine; N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine; Vandetanib DrugBank; CLUE; STITCH 59  NA
CID54529 1α,25-dihydroxy-2β-(3-hydroxypropoxy)cholecalciferol; Eldecalcitol DrugBank; CLUE; STITCH 1  NA
CID54530 Dha paclitaxel; Dha-paclitaxel; Paclitaxel 2'-(all-cis-4,7,10,13,16,19-docosahexaenoate); Paclitaxel docosahexaenoic acid; Paclitaxel docosahexaenoic acid ester DrugBank; STITCH 1  NA